Back to top

Image: Bigstock

Are Investors Undervaluing Centamin (CELTF) Right Now?

Read MoreHide Full Article

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.

Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.

One company value investors might notice is Centamin (CELTF - Free Report) . CELTF is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The stock holds a P/E ratio of 8.36, while its industry has an average P/E of 11.69. Over the last 12 months, CELTF's Forward P/E has been as high as 12.24 and as low as 5.73, with a median of 8.35.

Another valuation metric that we should highlight is CELTF's P/B ratio of 1.38. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. CELTF's current P/B looks attractive when compared to its industry's average P/B of 3.96. Over the past year, CELTF's P/B has been as high as 1.46 and as low as 0.80, with a median of 1.04.

These are just a handful of the figures considered in Centamin's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that CELTF is an impressive value stock right now.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Centamin (CELTF) - free report >>

Published in